Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Post by moneywagonon Jan 01, 2022 1:12pm

LESSONS LEARNED IN 2021 & THE PROMISE OF 2022

by @Goldfinger on 31 Dec 2021, 09:17 Year End Post: Lessons From 2021 & The Promise Of 2022      At the end of every year I ask readers what they learned in ...more  
122
Post by rwhittson Dec 31, 2021 3:51pm

Bids up

Bid 0.20 153,300 10 0.195 59,900 4 0.19 54,600 8
86
Post by rwhittson Dec 31, 2021 3:46pm

Bid ask

Ask 0.23 10,000 1 0.225 1,000 1 0.22 4,500 1 0.215 30,500 4 0.21  ...more  
106
Post by rwhittson Dec 31, 2021 2:00pm

Yes but asks at .22 .23

0.23 10,000 1 0.225 1,000 1 0.22 4,500
94
Post by moneywagonon Dec 31, 2021 11:35am

OK BIG BIOV BEAR @215 SIMPLY FEED THOSE DOWN INTO THE TEENS

and and and move on. Makes the sp stronger when the weak leave with less money!! hahaha...LOTS of bulls to take care of those shares. OH that Bear must not have gotten the memo...tax loss selling ...more  
86
Post by moneywagonon Dec 30, 2021 10:49am

BIOV TAKE A BOW AT THE HOLY GRAIL UNDER @20!! KABOOM!!

@19 Cheaper than some 3 year long holds here!!! 
60
Post by moneywagonon Dec 29, 2021 3:55pm

BIOV WONDER WHY SO MANY CEO FORUM CONTEST PICK BIOV? tee hee

28 Dec 2021, 11:57   @Filipino @Goldfinger Great interview! I know it's been mentioned here before the background of CEO James Passin and his large stake in ...more  
161
Post by Bomdrou999on Dec 23, 2021 9:11am

Manipulation...

by Anonymous. Finish soon! Be ready for a high ride!
103
Post by frankmanon Dec 22, 2021 3:53pm

Asks

Ask 0.25 6,500 3 0.245 20,000 2 0.24 10,000 3  ...more  
95
Post by frankmanon Dec 22, 2021 3:35pm

We will have news coming

On both the COVID and cancer vaccines plus the COVID diagnostic tool. We should be back to triple value. Have a Merry Christmas.
103
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities